InvestorsHub Logo
Followers 43
Posts 4314
Boards Moderated 0
Alias Born 09/01/2017

Re: longfellow95 post# 277322

Friday, 07/03/2020 4:19:38 PM

Friday, July 03, 2020 4:19:38 PM

Post# of 704576
The point regarding efficacy against particular subtypes being considered for approval is supported by the comment Dr LL made right after she stated everyone is living longer.

Paraphrasing, she said that there should be an approval path (which I took to mean at least for the subgroup(s) that appear to be benefiting like never before.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News